Gabrielsen Comments on Trump Administration’s Imposition of New Limits on ‘Guidance Documents’
February 10, 2018
The New York Times
Associate Lindsey Gabrielsen is quoted in a New York Times article, “Administration Imposes Sweeping Limits on Federal Actions Against Companies,” about the ramifications of the Justice Department’s adoption of new limits on the use of ‘guidance documents” by federal agencies.
In view of the new policy, Gabrielsen said, the government “will face serious hurdles” in enforcement actions based on violations of health care guidance documents.
Gabrielsen’s comments to the New York Times were also republished in Esquire, FierceHealthcare and MSN.
In view of the new policy, Gabrielsen said, the government “will face serious hurdles” in enforcement actions based on violations of health care guidance documents.
Gabrielsen’s comments to the New York Times were also republished in Esquire, FierceHealthcare and MSN.
Related News
August 19, 2025
In the News
Gustavo Resendiz Featured in Q&A on Secondary Market Momentum – 'Investors want liquidity'
Foley & Lardner LLP partner Gustavo Resendiz is featured in the Crunchbase News Q&A, "Why Secondary Funds Still Can’t Keep Up With Investor Demand," lending insight into the accelerating investor momentum towards secondary transactions.
August 18, 2025
In the News
David Simon Coauthors Piece on Empowering Lawyers as Strategic Business Partners
Foley & Lardner LLP partner David Simon coauthored The Agenda article, "Turn Your Corporate Lawyer into a Strategic Weapon," published by Financial Times.
August 15, 2025
In the News
Gregory Husisian on Voluntary Disclosures to Customs – 'Importing has never been riskier'
Foley & Lardner LLP partner Gregory Husisian authored the SupplyChainBrain article, "Best Practices for Making Voluntary Disclosures to Customs," sharing insight on this vital strategy for companies looking to mitigate risk from U.S. Customs and Border Protection.